Expressed genome molecular signatures of heart failure.
Traditional gene expression studies typically focus on one or a few genes of interest. An important limitation of single-gene studies is that they present a portrait of disease that is essentially static. However, disease is a dynamic process, driven by a combination of genetic, epigenetic and environmental factors. Recently, genomic technologies have permitted better characterization of the dynamic aspect of disease progression. Genome-wide expression profiles of cardiovascular diseases, heart failure in particular, using microarrays have been published and are providing new insights into this complex disease. Tissue biopsies required for traditional microarray studies, however, are often invasive and not readily available. By contrast, blood samples are relatively non-invasive and are readily available. In a number of recent studies, blood cells appear to be a viable substitute for tissue biopsy. Blood cells have the ability to mirror the body's tissues and organs in health and disease; thus, we hypothesize that blood cells can indicate at the molecular level the presence of disease. Here we review microarray gene expression profiling of blood RNA for a number of different diseases. Sieving through gene expression molecular signatures has identified groups of genes characteristic of each and has identified biomarkers associated with specific diseases.
Liew
Choong Chin
CC
Department of Medicine, Brigham and Women's Hospital, HMS, Boston, MA, USA. cliew@chondrogene.com
D020224:Expressed Sequence Tags; D020869:Gene Expression Profiling; D015894:Genome, Human; D023281:Genomics; D006333:Heart Failure / Q000235:genetics*; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis